Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis.

Transforming growth factor-beta1 (TGF-beta1) is thought to play a crucial role in fibrotic diseases. This study demonstrates for the first time that TGF-beta1 stimulation can induce myoblasts (C2C12 cells) to express TGF-beta1 in an autocrine manner, down-regulate the expression of myogenic proteins, and initiate the production of fibrosis-related proteins in vitro. Direct injection of human recombinant TGF-beta1 into skeletal muscle in vivo stimulated myogenic cells, including myofibers, to express TGF-beta1 and induced scar tissue formation within the injected area. We also observed the local expression of this growth factor by myogenic cells, including regenerating myofibers, in injured skeletal muscle. Finally, we demonstrated that TGF-beta1 gene-transfected myoblasts (CT cells) can differentiate into myofibroblastic cells after intramuscular transplantation, but that decorin, an anti-fibrosis agent, prevents this differentiation process by blocking TGF-beta1. In summary, these findings indicate that TGF-beta1 is a major stimulator that plays a significant role in both the initiation of fibrotic cascades in skeletal muscle and the induction of myogenic cells to differentiate into myofibroblastic cells in injured muscle.

[1]  A. Rostami,et al.  Demonstration and phenotypic characterization of resident macrophages in rat skeletal muscle. , 1990, Immunology.

[2]  E. Olson,et al.  Interplay between proliferation and differentiation within the myogenic lineage. , 1992, Developmental biology.

[3]  Yong Li,et al.  Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. , 2002, The American journal of pathology.

[4]  Freddie H. Fu,et al.  Suturing Versus Immobilization of a Muscle Laceration , 1999, The American journal of sports medicine.

[5]  Y. Kaneda,et al.  Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney , 1996, Nature Medicine.

[6]  J. Brockes,et al.  Amphibian Limb Regeneration: Rebuilding a Complex Structure , 1997, Science.

[7]  D. Brenner,et al.  Autocrine expression of activated transforming growth factor-beta(1) induces apoptosis in normal rat liver. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[8]  A. Pandit,et al.  The effect of TGF-beta delivered through a collagen scaffold on wound healing. , 1999, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[9]  L. Morandi,et al.  Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. , 1995, The Journal of clinical investigation.

[10]  R. Ross,et al.  Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. , 1987, The American journal of pathology.

[11]  M. Järvinen,et al.  Scar formation after skeletal muscle injury , 1986, Archives of orthopaedic and traumatic surgery.

[12]  R. Ahima,et al.  Functional improvement of dystrophic muscle by myostatin blockade , 2002, Nature.

[13]  E. Kovacs,et al.  Fibrogenic cytokines and connective tissue production , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  R. Braun,et al.  Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. , 1997, Biochemical pharmacology.

[15]  N. Habib,et al.  TGF-β1 inhibits HLA-DR and β2-microglobulin expression in HeLa cells induced with r-IFN , 1999 .

[16]  Freddie H. Fu,et al.  Use of Growth Factors to Improve Muscle Healing After Strain Injury , 2000, Clinical orthopaedics and related research.

[17]  J. Tidball,et al.  Inflammatory cell response to acute muscle injury. , 1995, Medicine and science in sports and exercise.

[18]  S. Odelberg,et al.  Dedifferentiation of Mammalian Myotubes Induced by msx1 , 2000, Cell.

[19]  W. Border,et al.  Transforming Growth Factor β in Tissue Fibrosis , 1994 .

[20]  Sally E. Johnson,et al.  Ras p21Val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors , 1995, Molecular and cellular biology.

[21]  U. Andersson,et al.  Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. , 1997, Arthritis and rheumatism.

[22]  M. Rudnicki,et al.  Reduced Differentiation Potential of Primary MyoD−/− Myogenic Cells Derived from Adult Skeletal Muscle , 1999, The Journal of cell biology.

[23]  S. Phan,et al.  Inhibition of Myofibroblast Apoptosis by Transforming Growth Factor β1 , 1999 .

[24]  Jeffrey B. Kopp,et al.  TGF- and fibrosis , 1999 .

[25]  B. Langley,et al.  Myostatin Inhibits Myoblast Differentiation by Down-regulating MyoD Expression* , 2002, The Journal of Biological Chemistry.

[26]  Se-Jin Lee,et al.  Regulation of myostatin activity and muscle growth , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Yong Li,et al.  Muscle injuries and repair: current trends in research. , 2002, The Journal of bone and joint surgery. American volume.

[28]  J. Montero,et al.  Transforming growth factor‐β1 induces collagen synthesis and accumulation via p38 mitogen‐activated protein kinase (MAPK) pathway in cultured L6E9 myoblasts , 2002 .

[29]  R. Derynck,et al.  TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. , 2001, Genes & development.

[30]  K. Miyazono,et al.  Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease. , 1993, The American journal of pathology.

[31]  R. Bucala,et al.  Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair , 1994, Molecular medicine.

[32]  E. Schultz,et al.  Response of satellite cells to focal skeletal muscle injury , 1985, Muscle & nerve.

[33]  Miranda D. Grounds,et al.  The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis. , 1993, Experimental cell research.

[34]  S. Dooley,et al.  Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts , 2000, Hepatology.

[35]  A. Moustakas,et al.  Role of Smad Proteins and Transcription Factor Sp1 in p21Waf1/Cip1 Regulation by Transforming Growth Factor-β* , 2000, The Journal of Biological Chemistry.

[36]  L Orci,et al.  Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Massagué,et al.  Type beta transforming growth factor is an inhibitor of myogenic differentiation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[38]  T. P. White,et al.  Satellite cell and growth factor involvement in skeletal muscle growth. , 1989, Medicine and science in sports and exercise.

[39]  S. Rosenkranz,et al.  Autocrine Regulation of TGF β Expression in Adult Cardiomyocytes , 1999 .

[40]  L. Sun,et al.  Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[41]  Johnny Huard,et al.  The Use of an Antifibrosis Agent to Improve Muscle Recovery after Laceration * , 2001, The American journal of sports medicine.

[42]  E. Ruoslahti,et al.  Localization of transforming growth factor beta binding site in betaglycan. Comparison with small extracellular matrix proteoglycans. , 1993, The Journal of biological chemistry.

[43]  J. Mordenti,et al.  Pharmacokinetics and Tissue Distribution of Recombinant Human Transforming Growth Factor Beta1 After Topical and Intravenous Administration in Male Rats , 1994, Pharmaceutical Research.

[44]  M. Selman,et al.  Platelet-derived growth factor in idiopathic pulmonary fibrosis. , 1990, The Journal of clinical investigation.

[45]  D. Warburton,et al.  Adenovirus-mediated decorin gene transfer prevents TGF-β-induced inhibition of lung morphogenesis. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[46]  R. Atkins,et al.  Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. , 1999, Kidney international.

[47]  E. Olson,et al.  Transforming growth factor beta represses the actions of myogenin through a mechanism independent of DNA binding. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Grounds,et al.  The exogenous administration of basic fibroblast growth factor to regenerating skeletal muscle in mice does not enhance the process of regeneration. , 1996, Growth factors.

[49]  E. Ruoslahti,et al.  Betaglycan has multiple binding sites for transforming growth factor-beta 1. , 1996, The Biochemical journal.

[50]  S. Odelberg,et al.  Mammalian myotube dedifferentiation induced by newt regeneration extract , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[51]  V. Petrov,et al.  Induction of cardiac fibrosis by transforming growth factor-beta(1). , 2000, Molecular genetics and metabolism.